Skip to content

Comparison of interocular changeover times for the lighting of the eyes in the swinging flashlight test in a pilot study

Comparison of interocular changeover times for the lighting of the eyes in the swinging flashlight test in a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024649
Enrollment
96
Registered
2022-03-24
Start date
2022-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H57

Interventions

Group 1: Patients with RAPD are recruited and tested using a swinging flashlight test with two varied time intervals to determine whether RAPD is better observed at one time interval. The randomized r

Sponsors

Augenklinik, Universitätsklinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients of legal age with RAPD at Heidelberg University Hospital, who can give a declaration of consent - Healthy adult individuals who do not have RAPD - Ophthalmologists and doctors in further training in ophthalmology who sign the declaration of consent

Exclusion criteria

Exclusion criteria: - Patients with efferent pupillary disorder - Patients with very poor pupillary reactions - No exclusion criterion for ophthalmologists and doctors in ophthalmological training

Design outcomes

Primary

MeasureTime frame
The target criteria are the Intraclass Correlation Coefficient (ICC) for comparing the agreement of the assessment of the test persons with different switching times. In addition, the detection rates of RAPD should be descriptively evaluated, taking into account the changeover times, as well as sensitivity and specificity.

Countries

Germany

Contacts

Public ContactGoeun Lee

Augenklinik, Universitätsklinikum

Goeun.lee@med.uni-heidelberg.de062215634339

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026